Generic selectors
Exact matches only
Search in title
Search in content
Post Type Selectors

SLNO – Soleno Therapeutics Inc

Soleno Therapeutics, Inc.
SLNO
$74.44
Name : Soleno Therapeutics, Inc.
Sector : Healthcare
Industry: Biotechnology
Mark. Cap: $3,751,322,112.00
EPSttm : -4.74
finviz dynamic chart for SLNO
Soleno Therapeutics, Inc.
$74.44
2.95%
$2.26

Float Short %

10.26

Margin Of Safety %

Put/Call OI Ratio

0.81

EPS Next Q Diff

EPS Last/This Y

4.38

EPS This/Next Y

Price

74.44

Target Price

107.67

Analyst Recom

1.11

Performance Q

50.69

Relative Volume

0.47

Beta

-2.69

Ticker: SLNO




22 items of 1

DateSymbolLastP/C OIP/C VolTotal OI
2025-04-14SLNO70.080.960.3799219
2025-04-15SLNO70.250.970.5198997
2025-04-16SLNO70.020.961.0099215
2025-04-17SLNO700.960.1299304
2025-04-18SLNO69.980.960.1499304
2025-04-21SLNO68.910.990.0327261
2025-04-22SLNO71.380.784.3830995
2025-04-23SLNO72.150.821.5632111
2025-04-24SLNO74.160.861.9334529
2025-04-25SLNO73.260.877939768011070.4830718414533435294
2025-04-28SLNO73.640.849324185951260.02702702702702736121
2025-04-29SLNO75.320.820.1736783
2025-04-30SLNO74.840.820.0037251
2025-05-01SLNO75.010.780.0338360
2025-05-02SLNO75.20.780.1338365
2025-05-05SLNO76.510.780.8938404
2025-05-06SLNO73.640.780.6138430
2025-05-07SLNO74.560.781.1738520
2025-05-08SLNO76.090.780.2639135
2025-05-09SLNO76.820.781.8639462
2025-05-12SLNO76.660.810.0041068
2025-05-13SLNO74.350.8127.8841086
DateSymbolLastP/C OIP/C VolTotal OI
22 items Current Page1 of 1




22 items of 1

DateTickerPriceCurrent Quarter Growth EstimateEBIT EstimationAverage EPS Estimate Current Year
2025-04-14SLNO70.00- - 0.00
2025-04-15SLNO70.25- - 0.00
2025-04-16SLNO70.00- - 0.00
2025-04-17SLNO69.98- - 0.00
2025-04-18SLNO69.98- - 0.00
2025-04-21SLNO68.91- - 0.00
2025-04-22SLNO71.40- - 0.00
2025-04-23SLNO72.27- - 0.00
2025-04-24SLNO74.18- - 0.00
2025-04-25SLNO73.26- - 0.00
2025-04-28SLNO73.64- - 0.00
2025-04-29SLNO75.27- - 0.00
2025-04-30SLNO74.86- - 0.00
2025-05-01SLNO75.02- - 0.00
2025-05-02SLNO75.23- - 0.00
2025-05-05SLNO76.49- - 0.00
2025-05-06SLNO73.63- - 0.00
2025-05-07SLNO74.66- - 0.00
2025-05-08SLNO76.10- - 0.00
2025-05-09SLNO76.78- - 0.00
2025-05-12SLNO76.70- - 0.00
2025-05-13SLNO74.44- - 0.00
DateTickerPriceCurrent Quarter Growth EstimateEBIT EstimationAverage EPS Estimate Current Year
22 items Current Page1 of 1




22 items of 1

DateTickerInsider TransactionsInstitutional TransactionsFloat Short
2025-04-14SLNO-23.967.2912.80
2025-04-15SLNO-23.967.2912.80
2025-04-16SLNO-23.967.2912.80
2025-04-17SLNO-23.967.2912.80
2025-04-18SLNO-23.967.2912.80
2025-04-21SLNO-23.968.7612.80
2025-04-22SLNO-23.968.7612.80
2025-04-23SLNO-23.968.7612.80
2025-04-24SLNO-23.968.7612.80
2025-04-25SLNO-22.468.7612.80
2025-04-28SLNO-22.467.9512.65
2025-04-29SLNO-22.467.9512.65
2025-04-30SLNO-22.467.9512.65
2025-05-01SLNO-22.467.9512.65
2025-05-02SLNO-22.467.9512.65
2025-05-05SLNO-22.457.5212.65
2025-05-06SLNO-22.457.5212.65
2025-05-07SLNO-22.467.5212.65
2025-05-08SLNO-22.467.5212.65
2025-05-09SLNO-22.467.5212.65
2025-05-12SLNO-22.29-3.2910.41
2025-05-13SLNO-23.27-3.2910.26
DateTickerInsider TransactionsInstitutional TransactionsFloat Short
22 items Current Page1 of 1

Last Quarter Act. EPS

Avg. EPS Est. Current Quarter

Avg. EPS Est. Next Quarter

Insider Transactions

-23.27

Institutional Transactions

-3.29

Beta

-2.69

Average Sales Estimate Current Quarter

3

Average Sales Estimate Next Quarter

11

Fair Value

Quality Score

9

Growth Score

25

Sentiment Score

84

Actual DrawDown %

8.1

Max Drawdown 5-Year %

-98.6

Target Price

107.67

P/E

Forward P/E

90.9

PEG

P/S

P/B

15.55

P/Free Cash Flow

EPS

-4.62

Average EPS Est. Cur. Y​

EPS Next Y. (Est.)

Target Price Estimates Raised

Target Price Estimates Lowered

Profit Margin

Relative Volume

0.47

Return on Equity vs Sector %

-95.4

Return on Equity vs Industry %

-78.5

EPS 1 7Days Diff

EPS 1 30Days Diff

EBIT Estimation

Soleno Therapeutics, Inc.
Sector: Healthcare
Industry: Biotechnology
Employees: 115
Soleno Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on the development and commercialization of novel therapeutics for the treatment of rare diseases. Its lead product candidate is Diazoxide Choline Extended-Release tablets, a once-daily oral tablet which is in Phase III clinical trials for the treatment of Prader-Willi Syndrome. The company was formerly known as Capnia, Inc. and changed its name to Soleno Therapeutics, Inc. in May 2017. Soleno Therapeutics, Inc. was incorporated in 1999 and is headquartered in Redwood City, California.
stock quote shares SLNO – Soleno Therapeutics Inc Stock Price stock today
news today SLNO – Soleno Therapeutics Inc stock forecast ,stock prediction 2023 2024 2025
marketwatch SLNO – Soleno Therapeutics Inc yahoo finance google finance
stock history SLNO – Soleno Therapeutics Inc invest stock market
stock prices SLNO premarket after hours
ticker SLNO fair value insiders trading